European Disease Registry on Retinopathy of Prematurity (ROP)

Recruiting Observational Study
Retinopathy of Prematurity
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
University Medicine Greifswald · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The EU-ROP registry is a European wide multicenter non-interventional observational registry study intended to run open-ended in as many countries as possible including infants treated for retinopathy of prematurity irrespective of the used treatment modality. The registry is strictly observational; only clinical routine data is collected, no study-specific examinations or interventions are to be …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ROP requiring treatment according to the respective national ROP screening and treatment guidelines Exclusion Criteria: * Denial or absence of consent for documentation and electronic storage of personal data by parents or legal guardians
Contacts

Andreas Stahl, Professor

+49 3834 86

andreas.stahl@med.uni-greifswald.de

CONTACT

Johanna M Pfeil, Dr

+49 3834 86

johanna.pfeil@med.uni-greifswald.de

CONTACT